MARKET WIRE NEWS
  1. Home
  2. Stock
  3. NERV
  4. News
NERV
Quote
Short
News
Articles
Message Board

Minerva Neurosciences Inc (NASDAQ : NERV ) News

News Releases

NERV News Releases
NERV : NASDAQ
GlobeNewswire
Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs
NERV : NASDAQ
GlobeNewswire
Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference
NERV : NASDAQ
SeekingAlpha
Minerva Neurosciences Non-GAAP EPS of -$0.17 misses by $0.04
NERV : NASDAQ
GlobeNewswire
Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates
NERV : NASDAQ
SeekingAlpha
Minerva launched with New Outperform at Citizens on schizophrenia candidate
NERV : NASDAQ
KlickAnalytics
Outperform Recommendation Issued On NERV By Citigroup
NERV : NASDAQ
GlobeNewswire
Minerva Announces Leadership Transition
NERV : NASDAQ
GlobeNewswire
Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
NERV : NASDAQ
SeekingAlpha
Minerva Neurosciences: Plodding Ahead After Another Roluperidone Delay In Negative Symptoms Of Schizophrenia
NERV : NASDAQ
GlobeNewswire
Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.